Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell Lymphoma
Clinical trial NCT01386398 · WITHDRAWN
Trial details
- NCT number
- NCT01386398
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.